Cargando…

CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy

Detalles Bibliográficos
Autores principales:	Ramachandran, Raja, Yadav, Ashok K., Kumar, Vinod, Gupta, Krishan L., Kohli, Harbir S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678839/ https://www.ncbi.nlm.nih.gov/pubmed/29142946 http://dx.doi.org/10.1016/j.ekir.2016.08.019

Ejemplares similares

Rituximab in Primary Membranous Nephropathy With Severe CKD
por: Naik, Sachin, et al.
Publicado: (2023)

Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
por: Naik, Sachin, et al.
Publicado: (2023)

Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and Cyclophosphamide
por: Ramachandran, Raja, et al.
Publicado: (2017)

Infusion of autologous bone marrow mononuclear cells leads to transient reduction in proteinuria in treatment refractory patients with Idiopathic membranous nephropathy
por: Sengupta, Upal, et al.
Publicado: (2013)

Long-Term Follow-Up of Cyclical Cyclophosphamide and Steroids Versus Tacrolimus and Steroids in Primary Membranous Nephropathy
por: Ramachandran, Raja, et al.
Publicado: (2021)

Rituximab in Membranous Nephropathy
por: Gauckler, Philipp, et al.
Publicado: (2021)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

Regulatory B Cells Are Reduced and Correlate With Disease Activity in Primary Membranous Nephropathy
por: Ramachandran, Raja, et al.
Publicado: (2020)

Membranous Nephropathy with Collapse: Poor Prognosis
por: Bharati, Joyita, et al.
Publicado: (2020)

Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report
por: Wang, Xiao-Pei, et al.
Publicado: (2016)

Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD
por: Hanset, Nicolas, et al.
Publicado: (2019)

Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience
por: Katsuno, Takayuki, et al.
Publicado: (2017)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study
por: Chen, Xian, et al.
Publicado: (2023)

Anti-phospholipase A2 receptor antibodies in membranous nephropathy
por: Lee, Sangho
Publicado: (2018)

A Rare Case Report of Emphysematous Cyst Infection in Autosomal Dominant Polycystic Kidney Disease
por: Sethi, Jasmine, et al.
Publicado: (2019)

Utility of Determining Autoantibodies to M-type Phospholipase A2 Receptor in Diagnosing Primary Membranous Nephropathy: An Ideal Setting
por: Ramachandran, R., et al.
Publicado: (2017)

Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience
por: Wang, Yao-Wei, et al.
Publicado: (2023)

Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy
por: Bandak, Ghassan, et al.
Publicado: (2014)

Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
por: Bagchi, Soumita, et al.
Publicado: (2018)

Gastrointestinal Involvement in Granulomatosis with Polyangiitis: Case Report and Review
por: Bagai, Sahil, et al.
Publicado: (2019)

Comparison of Two Steroid Regimens in Induction Therapy of Proliferative Lupus Nephritis: A Randomized Controlled Trial
por: Bharati, Joyita, et al.
Publicado: (2019)

Anti-phospholipase A2 receptor antibody and spontaneous remission in membranous nephropathy
por: Diaz, Montserrat, et al.
Publicado: (2018)

Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy
por: Vink, Coralien H., et al.
Publicado: (2022)

Anti-phospholipase A2 Receptor Antibody-Negative Membranous Nephropathy in Pregnancy
por: Saleem, Maryam, et al.
Publicado: (2023)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Recurrent idiopathic membranous nephropathy in the renal allograft: successful treatment with the anti-CD20 monoclonal antibody rituximab
por: Ladino, Marco, et al.
Publicado: (2009)

Current concepts on anti-Phospholipase A2 receptor antibody in Idiopathic membranous nephropathy
por: Ardalan, Mohammad Reza
Publicado: (2013)

Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy
por: Akiyama, Shin’ichi, et al.
Publicado: (2014)

Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts
por: Ardalan, Mohammad-Reza, et al.
Publicado: (2013)

A case report of breast cancer and membranous nephropathy with positive anti phospholipase A2 receptor antibodies
por: Mathew, David, et al.
Publicado: (2021)

A randomized trial of once daily versus twice daily dosing of oral iron in CKD
por: Sood, Vivek, et al.
Publicado: (2023)

Glomerulonephritis with Crescents in Polyomavirus Nephropathy
por: Sekar, Aravind, et al.
Publicado: (2022)

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Rituximab in patients with membranous nephropathy and kidney insufficiency
por: Guo, Yanhong, et al.
Publicado: (2022)

Existing creatinine-based equations overestimate glomerular filtration rate in Indians
por: Kumar, Vivek, et al.
Publicado: (2018)

Poor Outcome after Hospital Discharge in Patients with ESKD and COVID-19
por: Sethi, Jasmine, et al.
Publicado: (2023)

Anti-Nuclear Antibody-Negative Lupus Nephritis or Post-Infectious Glomerulonephritis: Diagnostic Dilemma in a Young Male
por: Bharati, Joyita, et al.
Publicado: (2021)

Role of Anti-Phospholipase A(2) Receptor Antibodies in the Differential Diagnosis of Diabetic and Membranous Nephropathy
por: Pocivalnik, Mirjam, et al.
Publicado: (2013)

Anti-Phospholipase A2 Receptor Antibody Expression at Different Stages of Idiopathic Membranous Nephropathy
por: Fu, Keying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oj1hlg4p8kqltsb8sijdu6rtkb